| Expression pattern: |
UP |
| Associated gene: |
EZH2 |
| Associated microRNA: |
miR-217 |
| Biological function: |
promotes cell proliferation, cell cycle progression, migration, invasion, EMT, tumor growth and metastasis in gallbladder cancer |
| Molecular mechanism: |
ceRNA mechanism: circTP63 sponges miR-217 to de-repress EZH2 expression, facilitating tumor progression |
| Biological pathway or process: |
proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); EMT (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Survival Analysis; Transfection; CCK8; Cell Cycle Assay; Transwell Assay; Luciferase Reporter Assay; RNA Pull-Down; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry) |
| Clinical significance: |
Higher circTP63 expression was associated with lymph node metastasis and short overall survival (OS) in patients with GBC; circTP63 expression could be a prognostic maker for GBC. |
| Description: |
circTP63 is up-regulated in gallbladder cancer tissues and cell lines and promotes proliferation, cell-cycle progression, migration/invasion and EMT. It acts as a ceRNA by sponging miR-217 to increase EZH2 expression, thereby facilitating tumor progression; high circTP63 predicts poorer overall survival and is associated with lymph node metastasis. |
| Confidence score: |
0.8227 |